Edition:
United Kingdom

BeyondSpring Inc (BYSI.OQ)

BYSI.OQ on NASDAQ Stock Exchange Capital Market

21.30USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$21.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,330
52-wk High
$34.01
52-wk Low
$16.83

Chart for

About

BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $892.10
Shares Outstanding(Mil.): 22.84
Dividend: --
Yield (%): --

Financials

  BYSI.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -3.97 -- --
ROI: -268.89 0.29 15.02
ROE: -260.45 0.94 16.60

Earnings vs. Estimates